Study seeks to understand how different forms of data meet the needs of researchers.
Peter Mesenbrink
Advertisement
Peter Mesenbrink, Executive Director, Biostatistics, Novartis
Articles by Peter Mesenbrink
Advertisement
Latest Updated Articles
- Establishing a Basis for Secondary Use Standards for Clinical Trials
Published: March 8th 2023 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Thermo Fisher, Lundbeck Announce New OpenAI Partnerships Advancing AI in Drug Development
2
Using Global Patient Data to Design Smarter, More Inclusive Clinical Trials
3
ACT Brief: AI Expands Global Site Leadership as Ozempic Shows Potential to Reverse Biological Age
4
Building Broader Investigator Networks to Advance Global Breast Cancer Research
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
